ENZ (Enzo Biochem Inc.) Rasio rega marang prakiraan pendapatan
Enzo Biochem, Inc. (ENZ) relies on the sale of proprietary tests, which guarantees a stable cash flow. The forward price-to-sales ratio confirms the current market valuation, where 0.60 describes the current status of the metric. Environmental initiatives help reduce laboratory waste, while a strong R&D team and the recruitment of compliance experts ensure the development of global distribution.
Rincian analitis perusahaan Enzo Biochem, Inc.
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Total Utang marang Modal Enzo Biochem, Inc.|ENZ - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Enzo Biochem|ENZ - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Enzo Biochem, Inc.|ENZ - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Enzo Biochem|Rasio cepet enzo.com
- indikator pendapatan resik lan kelipatan nilai:
ENZ - Penghasilan resik perusahaan|Bathi sing dikarepake Enzo Biochem, Inc.|ENZ - Koefisien rega marang bathi|Prakiraan rega marang bathi Enzo Biochem|ENZ - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Enzo Biochem, Inc.|ENZ - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Enzo Biochem|ENZ - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan enzo.com|ENZ - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Enzo Biochem, Inc.
- statistik dodolan lan pendapatan perusahaan:
Analisis wiwitan perusahaan:Enzo ENZ
This indicator compares market capitalization with expected revenue, reflecting the valuation's sensitivity to operating cash flow dynamics and margins. By outsourcing IT infrastructure while retaining rights to chemical methodologies, Enzo Biochem, Inc. (ENZ) optimizes costs, making the projected P/S ratio on the GURU.Markets platform an accurate tool for analyzing business resilience and the growth potential of asset value.
Pesaing Enzo Biochem, Inc. (ENZ)
Agilent - Multiplikator forward rega marang pendapatan|DGX (Quest Diagnostics Inc.) - Rega mangsa ngarep marang pendapatan|ILMN - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Exact Sciences Inc.|RVTY (Revvity, Inc.) - Multiplikator forward rega marang pendapatan|bio-rad.com - Rega forward marang dodolan|NNNN (Anbio) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan SHC|Multiplikator Forward P/S QDEL|Rasio kapitalisasi marang dodolan sing dikarepake OPKO Health Corp.|Rasio rega marang prakiraan pendapatan CareDx, Inc CDNA|maravai.com (MRVI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Fulgent Genetics - Multiplikator Forward P/S|Standard BioTools Inc (LAB) - Multiplikator forward rega marang pendapatan|CTKB: Multiplikator Forward P/S|OraSure Corp - Rega forward marang dodolan|XGN (Exagen Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep mdxhealth.com MDXH|Rasio rega marang prakiraan pendapatan Lucid Diagnostics (LUCD)|Multiplikator forward rega marang pendapatan prenetics.com PRE|Insight Molecular Diagnostics Inc - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan TRIB|ProPhase Labs, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake ainos.com AIMD|Co-Diagnostics (CODX) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan HSCS|BMRA (Biomerica, Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Cardio Diagnostics Holdings, Inc. (CDIO)|Multiplikator forward rega marang pendapatan ONCO (Onconetix, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake viraxbiolabs.com|Multiplikator Forward P/S BJDX (Bluejay Diagnostics, Inc.)|Aspira Women's Health, Inc. (AWH) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|AXDX - Rasio rega marang prakiraan pendapatan|CNTG (CENTOGENE) - Kapitalisasi marang prakiraan pendapatan|FRES (fresh2.co) - Multiplikator forward rega marang pendapatan|Rega mangsa ngarep marang pendapatan GENE (Genetic Technologies Limited)|Rasio rega marang prakiraan pendapatan 23andMe|Multiplikator forward rega marang pendapatan Psychemedics Corp. (PMD)
